These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 33361602)

  • 21. Roles of tau pathology in the locus coeruleus (LC) in age-associated pathophysiology and Alzheimer's disease pathogenesis: Potential strategies to protect the LC against aging.
    Satoh A; Iijima KM
    Brain Res; 2019 Jan; 1702():17-28. PubMed ID: 29274876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Knockdown of orexin type 1 receptor in rat locus coeruleus increases REM sleep during the dark period.
    Chen L; McKenna JT; Bolortuya Y; Winston S; Thakkar MM; Basheer R; Brown RE; McCarley RW
    Eur J Neurosci; 2010 Nov; 32(9):1528-36. PubMed ID: 21089218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of an OX2R agonist on migration and removal of tau from mouse brain.
    Terada M; Mitsukawa K; Nakakariya M; Koike T; Kimura H
    Sci Rep; 2024 Jul; 14(1):15964. PubMed ID: 38987562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TAK-994, a Novel Orally Available Brain-Penetrant Orexin 2 Receptor-Selective Agonist, Suppresses Fragmentation of Wakefulness and Cataplexy-Like Episodes in Mouse Models of Narcolepsy.
    Ishikawa T; Hara H; Kawano A; Tohyama K; Kajita Y; Miyanohana Y; Koike T; Kimura H
    J Pharmacol Exp Ther; 2023 Jun; 385(3):193-204. PubMed ID: 37001988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Orexin modulates behavioral fear expression through the locus coeruleus.
    Soya S; Takahashi TM; McHugh TJ; Maejima T; Herlitze S; Abe M; Sakimura K; Sakurai T
    Nat Commun; 2017 Nov; 8(1):1606. PubMed ID: 29151577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. No loss of orexin/hypocretin, melanin-concentrating hormone or locus coeruleus noradrenergic neurons in a rat model of chronic sleep restriction.
    Deurveilher S; Antonchuk M; Saumure BSC; Baldin A; Semba K
    Eur J Neurosci; 2021 Sep; 54(6):6027-6043. PubMed ID: 34355453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Locus Coeruleus and Tuberomammillary Nuclei Ablations Attenuate Hypocretin/Orexin Antagonist-Mediated REM Sleep.
    Schwartz MD; Nguyen AT; Warrier DR; Palmerston JB; Thomas AM; Morairty SR; Neylan TC; Kilduff TS
    eNeuro; 2016; 3(2):. PubMed ID: 27022631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemogenetic locus coeruleus activation restores reversal learning in a rat model of Alzheimer's disease.
    Rorabaugh JM; Chalermpalanupap T; Botz-Zapp CA; Fu VM; Lembeck NA; Cohen RM; Weinshenker D
    Brain; 2017 Nov; 140(11):3023-3038. PubMed ID: 29053824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sleep-Wake Cycle in Alzheimer's Disease Is Associated with Tau Pathology and Orexin Dysregulation.
    Liguori C; Spanetta M; Izzi F; Franchini F; Nuccetelli M; Sancesario GM; Di Santo S; Bernardini S; Mercuri NB; Placidi F
    J Alzheimers Dis; 2020; 74(2):501-508. PubMed ID: 32065791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distribution of orexin receptor mRNA in the rat brain.
    Trivedi P; Yu H; MacNeil DJ; Van der Ploeg LH; Guan XM
    FEBS Lett; 1998 Oct; 438(1-2):71-5. PubMed ID: 9821961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Whole Brain Mapping of Orexin Receptor mRNA Expression Visualized by Branched In Situ Hybridization Chain Reaction.
    Tsuneoka Y; Funato H
    eNeuro; 2024 Feb; 11(2):. PubMed ID: 38199807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Orexin Receptor Antagonism Improves Sleep and Reduces Seizures in Kcna1-null Mice.
    Roundtree HM; Simeone TA; Johnson C; Matthews SA; Samson KK; Simeone KA
    Sleep; 2016 Feb; 39(2):357-68. PubMed ID: 26446112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of orexin (hypocretin) on GIRK channels.
    Hoang QV; Bajic D; Yanagisawa M; Nakajima S; Nakajima Y
    J Neurophysiol; 2003 Aug; 90(2):693-702. PubMed ID: 12702704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential sleep/wake response and sex differences following acute suvorexant, MK-1064 and zolpidem administration in the rTg4510 mouse model of tauopathy.
    Keenan RJ; Daykin H; Chu J; Cornthwaite-Duncan L; Allocca G; Hoyer D; Jacobson LH
    Br J Pharmacol; 2022 Jul; 179(13):3403-3417. PubMed ID: 35112344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
    Helboe L; Egebjerg J; Barkholt P; Volbracht C
    Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Critical role of somatostatin receptor 2 in the vulnerability of the central noradrenergic system: new aspects on Alzheimer's disease.
    Ádori C; Glück L; Barde S; Yoshitake T; Kovacs GG; Mulder J; Maglóczky Z; Havas L; Bölcskei K; Mitsios N; Uhlén M; Szolcsányi J; Kehr J; Rönnbäck A; Schwartz T; Rehfeld JF; Harkany T; Palkovits M; Schulz S; Hökfelt T
    Acta Neuropathol; 2015 Apr; 129(4):541-63. PubMed ID: 25676386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease.
    Liguori C; Romigi A; Nuccetelli M; Zannino S; Sancesario G; Martorana A; Albanese M; Mercuri NB; Izzi F; Bernardini S; Nitti A; Sancesario GM; Sica F; Marciani MG; Placidi F
    JAMA Neurol; 2014 Dec; 71(12):1498-505. PubMed ID: 25322206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonpeptide orexin type-2 receptor agonist ameliorates narcolepsy-cataplexy symptoms in mouse models.
    Irukayama-Tomobe Y; Ogawa Y; Tominaga H; Ishikawa Y; Hosokawa N; Ambai S; Kawabe Y; Uchida S; Nakajima R; Saitoh T; Kanda T; Vogt K; Sakurai T; Nagase H; Yanagisawa M
    Proc Natl Acad Sci U S A; 2017 May; 114(22):5731-5736. PubMed ID: 28507129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intermittent Short Sleep Results in Lasting Sleep Wake Disturbances and Degeneration of Locus Coeruleus and Orexinergic Neurons.
    Zhu Y; Fenik P; Zhan G; Somach R; Xin R; Veasey S
    Sleep; 2016 Aug; 39(8):1601-11. PubMed ID: 27306266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Orexin and Alzheimer's Disease.
    Liguori C
    Curr Top Behav Neurosci; 2017; 33():305-322. PubMed ID: 28012089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.